Impact of black tea on forearm endothelial functionDe invloed van zwarte thee op de vaatfunctie
- Conditions
- Vascular functionendothelial functionblack teahealthy volunteersendotheelgezonde vrijwilligershypertensieblood flowblood pressurehypertensionvaatfunctie
- Registration Number
- NL-OMON25147
- Lead Sponsor
- Department of Physiology, section of Integrative Physiology, Radboudumc Nijmegen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Healthy subjects:
- Males and post-menopausal (> 1 years) females
- Aged >45 and < 75 years
- Body mass index (BMI) between 18.0 and „T35.0 kg
- Regular performance of strenuous exercise/sport of > 2 hours per week
- Current smoker or has stopped smoking less than 6 months before start of study
- Self reported alcohol intake of >21 units/week)
- Established cardiovascular disease
- Diabetes mellitus
- Blood pressure > 160/100 mmHg
- Subjects taking any medication that might affect endothelial function (e.g. but not limited to beta-blockers, ACE-inhibitors, statins, anti-coagulants, anti-depressants, hormone replacement therapy) will be excluded from the study. Subjects who are on stable medication for which there is no indication of an effect on endothelial function, will be allowed to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean forearm blood flow response (volume change measured by venous occlusion plethysmography) to intra-arterially administered acetylcholine (i.e. endothelium-independent vasodilation)
- Secondary Outcome Measures
Name Time Method Mean forearm blood flow response (volume change measured by venous occlusion plethysmography) to intra-arterially administered sodium nitroprusside (i.e. endothelium-dependent vasodilation);<br>Mean forearm blood flow response (volume change measured by venous occlusion plethysmography) to intra-arterially administered sodium L-NMMA(i.e. nitric oxide-blocker; endothelium-dependent vasoconstriction)